20
Amoli Organics Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OXCARBAZEPINE USP, with a corresponding US DMF Number 23191.
Remarkably, this DMF maintains an Active status since its submission on October 20, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 16, 2017, and payment made on October 16, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II